Zulma Gazit
Zulma Gazit
Hebrew University, Israel; Cedars-Sinai Medical Center, USA
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
S Beyth, Z Borovsky, D Mevorach, M Liebergall, Z Gazit, H Aslan, E Galun, ...
Blood 105 (5), 2214-2219, 2005
Evidence for skeletal progenitor cells in the degenerate human intervertebral disc
MV Risbud, A Guttapalli, TT Tsai, JY Lee, KG Danielson, AR Vaccaro, ...
Spine 32 (23), 2537-2544, 2007
Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation
J Kahn, T Byk, L Jansson-Sjostrand, I Petit, S Shivtiel, A Nagler, I Hardan, ...
Blood 103 (8), 2942-2949, 2004
Osteogenic Differentiation of Noncultured Immunoisolated Bone Marrow‐Derived CD105+ Cells
H Aslan, Y Zilberman, L Kandel, M Liebergall, RJ Oskouian, D Gazit, ...
Stem cells 24 (7), 1728-1737, 2006
Nucleofection-Based Ex Vivo Nonviral Gene Delivery to Human Stem Cells as a Platform for Tissue Regeneration
H Aslan, Y Zilberman, V Arbeli, D Sheyn, Y Matan, M Liebergall, JZ Li, ...
Tissue engineering 12 (4), 877-889, 2006
Stem cells as vehicles for orthopedic gene therapy
Y Gafni, G Turgeman, M Liebergal, G Pelled, Z Gazit, D Gazit
Gene Therapy 11 (4), 417-426, 2004
Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system
Y Gafni, G Pelled, Y Zilberman, G Turgeman, F Apparailly, H Yotvat, ...
Molecular Therapy 9 (4), 587-595, 2004
Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion
D Sheyn, G Pelled, Y Zilberman, F Talasazan, JM Frank, D Gazit, Z Gazit
Stem cells 26 (4), 1056-1064, 2008
Stem cell–based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study
M Liebergall, J Schroeder, R Mosheiff, Z Gazit, Z Yoram, L Rasooly, ...
Molecular Therapy 21 (8), 1631-1638, 2013
Ultrasound-based nonviral gene delivery induces bone formation in vivo
D Sheyn, N Kimelman-Bleich, G Pelled, Y Zilberman, D Gazit, Z Gazit
Gene therapy 15 (4), 257-266, 2008
Gene-modified adult stem cells regenerate vertebral bone defect in a rat model
D Sheyn, I Kallai, W Tawackoli, D Cohn Yakubovich, A Oh, S Su, X Da, ...
Molecular pharmaceutics 8 (5), 1592-1601, 2011
Human induced pluripotent stem cells differentiate into functional mesenchymal stem cells and repair bone defects
D Sheyn, S Ben-David, G Shapiro, S De Mel, M Bez, L Ornelas, ...
Stem cells translational medicine 5 (11), 1447-1460, 2016
Mesenchymal stem cells for bone gene therapy and tissue engineering
G Pelled, G Turgeman, H Aslan, Z Gazit, D Gazit
Current Pharmaceutical Design 8 (21), 1917-1928, 2002
Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair
N Kimelman-Bleich, G Pelled, Y Zilberman, I Kallai, O Mizrahi, ...
Molecular Therapy 19 (1), 53-59, 2011
In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs
M Bez, D Sheyn, W Tawackoli, P Avalos, G Shapiro, JC Giaconi, X Da, ...
Science translational medicine 9 (390), eaal3128, 2017
The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo
N Kimelman-Bleich, G Pelled, D Sheyn, I Kallai, Y Zilberman, O Mizrahi, ...
Biomaterials 30 (27), 4639-4648, 2009
BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells
O Mizrahi, D Sheyn, W Tawackoli, I Kallai, A Oh, S Su, X Da, P Zarrini, ...
Gene therapy 20 (4), 370-377, 2013
Microcomputed tomography–based structural analysis of various bone tissue regeneration models
I Kallai, O Mizrahi, W Tawackoli, Z Gazit, G Pelled, D Gazit
Nature Protocols 6 (1), 105-110, 2011
Genetically modified cells in regenerative medicine and tissue engineering
D Sheyn, O Mizrahi, S Benjamin, Z Gazit, G Pelled, D Gazit
Advanced drug delivery reviews 62 (7-8), 683-698, 2010
Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures
G Pelled, A Ben-Arav, C Hock, DG Reynolds, C Yazici, Y Zilberman, ...
Tissue Engineering Part B: Reviews 16 (1), 13-20, 2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20